View 3 related solutions for
Alliance Site Strategy
Reliable recruitment of patients is a fundamental need in clinical trials. Recruitment difficulties can translate into significant delays in getting new, cutting-edge medicines to patients as well as impact revenue generation.
PAREXEL provides a strategic relationship-driven approach to address one of the most critical challenges in the clinical trials journey – the patient enrollment process. PAREXEL’s Site Alliance Network has the quality relationships and expertise to help clients meet their clinical trial recruiting and enrollment needs.
The Site Alliance Network consists of approximately 300 member organizations as well as several site management organizations (SMOs), together providing access to approximately 6,000 investigators worldwide. The site management organizations alone have a combined database of 7.5 million patients in more than 20 countries. The network’s size and scope enable faster patient recruitment, foster greater collaboration between PAREXEL and sites on behalf of clients and ensure quality across multiple sites.
Recently, PAREXEL used one of its Site Alliance network partnerstorecruit more than 8,250 people across 40 sites for a Phase III clinical trial. The team was able to randomize the first patient within eight weeks of final protocol being available and delivered the targeted number of patients 2 months ahead of schedule, helping create a cost saving of close to 40 percent.
Through PAREXEL’s Site Alliance Network, clients are better able to help improve patient enrolment and accelerate the pace of clinical trials – making it possible to reduce time to market.